BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31570656)

  • 1. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
    Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
    Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
    Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
    Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
    Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actionable mutations in canine hemangiosarcoma.
    Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
    PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
    Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
    Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.
    Teruyama F; Kuno A; Murata Y; Nakagawa T; Shiba-Ishii A; Yuguchi S; Noguchi M
    Pathol Int; 2022 Sep; 72(9):457-463. PubMed ID: 35801418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
    Beca F; Krings G; Chen YY; Hosfield EM; Vohra P; Sibley RK; Troxell ML; West RB; Allison KH; Bean GR
    Mod Pathol; 2020 Aug; 33(8):1518-1526. PubMed ID: 32123305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
    Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
    PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
    Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
    Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.
    Italiano A; Chen CL; Thomas R; Breen M; Bonnet F; Sevenet N; Longy M; Maki RG; Coindre JM; Antonescu CR
    Cancer; 2012 Dec; 118(23):5878-87. PubMed ID: 22648906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
    Cobleigh MA; Layng KV; Mauer E; Mahon B; Hockenberry AJ; Abukhdeir AM
    Breast Cancer Res Treat; 2024 Apr; 204(2):407-414. PubMed ID: 38153569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds.
    Alsaihati BA; Ho KL; Watson J; Feng Y; Wang T; Dobbin KK; Zhao S
    Nat Commun; 2021 Aug; 12(1):4670. PubMed ID: 34344882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
    Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
    Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
    Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
    Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma.
    Wan H; Zhang D; Hu W; Xie Z; Du Q; Xia Q; Wen T; Jia H
    Medicine (Baltimore); 2021 Jul; 100(30):e26779. PubMed ID: 34397726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.
    Tonomura N; Elvers I; Thomas R; Megquier K; Turner-Maier J; Howald C; Sarver AL; Swofford R; Frantz AM; Ito D; Mauceli E; Arendt M; Noh HJ; Koltookian M; Biagi T; Fryc S; Williams C; Avery AC; Kim JH; Barber L; Burgess K; Lander ES; Karlsson EK; Azuma C; Modiano JF; Breen M; Lindblad-Toh K
    PLoS Genet; 2015 Feb; 11(2):e1004922. PubMed ID: 25642983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.